Development of CpG-Oligodeoxynucleotides for effective activation of rabbit TLR9 mediated immune responses

Tsung Hsien Chuang*, Chao Yang Lai, Ping Hui Tseng, Chiun Jye Yuan, Li Chung Hsu

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Abstract

CpG-oligodeoxynucleotides (CpG-ODN) are potent immune stimuli being developed for use as adjuvants in different species. Toll-like receptor 9 (TLR9) is the cellular receptor for CpG-ODN in mammalian cells. The CpG-ODN with 18-24 deoxynucleotides that are in current use for human and mouse cells, however, have low activity with rabbit TLR9. Using a cell-based activation assay, we developed a type of CpG-ODN containing a GACGTT or AACGTT motif in 12 phosphorothioate-modified deoxynucleotides with potent stimulatory activity for rabbit TLR9. The developed CpG-ODN have higher activities than other developed CpG-ODN in eliciting antigen-nonspecific immune responses in rabbit splenocytes. When mixed with an NJ85 peptide derived from rabbit hemorrhagic disease virus, they had potent activities to boost an antigen-specific T cell activation and antibody production in rabbits. Compared to Freund's adjuvant, the developed CpG-ODN are capable of boosting a potent and less toxic antibody response. The results of this study suggest that both the choice of CpG-motif and its length are important factors for CpG-ODN to effectively activate rabbit TLR9 mediated immune responses.

Original languageEnglish
Article numbere108808
JournalPLoS ONE
Volume9
Issue number9
DOIs
StatePublished - 30 Sep 2014

Fingerprint

Dive into the research topics of 'Development of CpG-Oligodeoxynucleotides for effective activation of rabbit TLR9 mediated immune responses'. Together they form a unique fingerprint.

Cite this